β-Lactam Antibiotics: Structure, Mechanism, and Resistance

    β-Lactam antibiotics are among the most important and widely used antimicrobial agents. Their discovery in the 1930s and development throughout the 20th century revolutionized the treatment of bacterial infections. All β-lactam antibiotics share a core structural feature: the β-lactam ring, which is essential for their antibacterial activity.

Structure and Subclasses

    The β-lactam ring is a four-membered cyclic amide (azetidinone) that is chemically reactive due to ring strain. Variations in side chains and additional fused rings lead to the formation of different β-lactam subclasses:

  • Penicillins (e.g., penicillin G, ampicillin)
    → Saturated five-membered ring fused to β-lactam

  • Cephalosporins (e.g., cefotaxime)
    → Unsaturated six-membered ring fused to β-lactam

  • Carbapenems (e.g., imipenem, PZ-601)
    → Unsaturated five-membered ring with broader spectrum

  • Monobactams (e.g., aztreonam)
    → Contain only the β-lactam ring without fusion to another ring

Mechanism of Action

    All β-lactams inhibit bacterial cell wall biosynthesis by binding to penicillin-binding proteins (PBPs)—enzymes responsible for the final cross-linking of peptidoglycan strands. By inactivating PBPs, β-lactams prevent proper cell wall formation, leading to cell lysis and death.

Resistance Mechanisms

Bacterial resistance to β-lactam antibiotics can arise through several mechanisms:

  • Production of β-lactamases: Enzymes that hydrolyze the β-lactam ring (e.g., penicillinase, cephalosporinase).

  • Modification of PBPs: Some bacteria, such as MRSA, produce altered PBPs with reduced affinity for β-lactams.

  • Decreased permeability or efflux: Especially in Gram-negative bacteria, outer membrane porins may be lost or altered to prevent drug entry, or active efflux systems remove the antibiotic from the cell.

To counteract resistance, β-lactamase inhibitors such as clavulanic acid, sulbactam, and tazobactam are used in combination with β-lactam antibiotics. New inhibitors like BAL29880 (β-lactam-based) and NXL104 (non-β-lactam) have also been developed

New Developments

The development of semisynthetic and next-generation β-lactams has produced drugs such as:

  • CXA-101: A cephalosporin with potent activity against Pseudomonas aeruginosa

  • Ceftaroline and ceftobiprole: 5th-generation cephalosporins effective against MRSA

  • ME-1036 and PZ-601: Carbapenems with improved activity against resistant strains

  • BAL-30072: A monobactam with a siderophore group for improved bacterial uptake.
Clinical Use

β-Lactam antibiotics are used to treat:

  • Respiratory tract infections

  • Urinary tract infections

  • Skin and soft tissue infections

  • Sepsis and meningitis

They are typically well-tolerated, though allergic reactions (especially to penicillin) are common.


References

All information presented in this article is based on:

Maffioli, Sonia Ilaria. “A Chemist’s Survey of Different Antibiotic Classes.” In Antibiotics: Targets, Mechanisms and Resistance, edited by Claudio O. Gualerzi, Letizia Brandi, Attilio Fabbretti, and Cynthia L. Pon, Wiley-VCH Verlag GmbH & Co. KGaA, 2014, pp. 1–4. 

Note:

  • This article is still under development, and the information it contains may change as scientific research progresses.
  • Please be aware that specific details presented in this source may vary and require direct access to the original source for further information about the content described.

Komentar

Postingan populer dari blog ini

PEMERAN pendukung

Menjadi Normal